The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ECOG-ACRIN EAA181: Effective quadruplet utilization after treatment evaluation (EQUATE)—a randomized phase 3 trial for newly diagnosed multiple myeloma (NDMM) not intended for early autologous transplantation.
 
Shaji Kumar
Consulting or Advisory Role - Abbvie (Inst); Abbvie (Inst); Amgen (Inst); Bluebird Bio (Inst); Celgene (Inst); Cellectar; Genecentrix; Genentech/Roche (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); Merck (Inst); Molecular Partners (Inst); Oncopeptides; Takeda (Inst)
Research Funding - Abbvie (Inst); CARsgen Therapeutics (Inst); Celgene (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst); Sanofi (Inst); Takeda (Inst); TeneoBio (Inst)
 
Zihan Wei
No Relationships to Disclose
 
Michael A. Thompson
Stock and Other Ownership Interests - Doximity
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; AIM Specialty Health; Celgene; GlaxoSmithKline; GRAIL; Strata Oncology; Syapse; Takeda; VIA Oncology
Research Funding - Abbvie (Inst); Amgen (Inst); ARMO BioSciences (Inst); Bristol-Myers Squibb (Inst); Cancer Research and Biostatistics (Inst); Denovo Biopharma (Inst); GlaxoSmithKline (Inst); Lynx Biosciences (Inst); PrECOG (Inst); Strata Oncology (Inst); Takeda (Inst); TG Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate, Peer Review for Plasma Cell Dyscrasias (Editor: Robert Kyle)
Travel, Accommodations, Expenses - GlaxoSmithKline; Syapse; Takeda
Other Relationship - Doximity
 
Bradley Snyder
No Relationships to Disclose
 
Matthias Weiss
No Relationships to Disclose
 
Lynne I. Wagner
Stock and Other Ownership Interests - Gilead Sciences (I); Johnson & Johnson (I); Lilly (I)
Consulting or Advisory Role - Athenex; Celgene
Travel, Accommodations, Expenses - Celgene
 
Lale Kostakoglu
Honoraria - Novartis
Consulting or Advisory Role - BeiGene; ImaginAb; Roche/Genentech
Travel, Accommodations, Expenses - Roche
 
S. Vincent Rajkumar
Patents, Royalties, Other Intellectual Property - Authorship Royalties from Up To Date